Recent Posts
- Lawsuit Prompts U.S. State Department To Strengthen Protections Of HIV-Positive Contract Workers
- San Francisco Postpones Agency Cuts, Los Angeles AIDS Clearinghouse Closes
- Kennedy’s Contributions To HIV/AIDS, Gay Rights Policies Recalled
- Routine Circumcision Does Not Protect Against HIV For Men Who Have Sex With Men, CDC Study Finds
- NBA Legend Dikembe Mutombo, UNICEF Executive Director Ann M. Veneman And BD Commemorate Opening Of New Center To Improve HIV/AIDS Treatment In The DRC
Random Posts
- Don't Make Assumptions About HIV - A Major New Campaign Tells Gay Men, UK
- GlaxoSmithKline Pledges $97M Investment In AIDS Drugs For Africa, Allows South African Drugmaker To Produce Generic Second-Line Treatment
- Denver Post Examines Efforts To Establish Needle-Exchange Programs In Colorado
- Many U.S. Residents Test Positive For HIV Late In Illness, Few High School Students
- Washington Post Examines HIV/AIDS Rights, Responsibilities Questions
- Ohr Pharmaceutical Data Review Supports The Strong Potential Of Its Lead Drug OHR/AVR118 For Cachexia
- Grandmother Network Strong Force In HIV/AIDS Efforts, HIV Advocate Lewis Says
- MSF Calls For Sustained Commitment To Global HIV/AIDS Funding
- More Camden, N.J., Residents Using Needle Exchange Programs
- Michigan Lawmakers Approve Request For State Health Agency To Use Private Funds For HIV/AIDS Program
Prescription AIDS Drugs
Contact Us
10th Functional Genomics: Chemical Biology 2009
August 24th, 2009
A cure for cystic fibrosis, HIV-fighting ‘Trojan horses’, new pharmaceuticals from the ocean. Chemical biologists use new and innovative approaches to discover medications of the future. On 24 August, some of the field’s most prominent researchers will attend an international conference in Gothenburg, Sweden.
In the field of chemical biology, chemists and biologists cooperate to investigate, and eventually control, the behavior of cells. The scientists use small molecules that activate certain proteins to study how cells communicate, and ultimately they want to be able to prevent disease-causing interactions and understand how medicines and environmental toxins work on a cellular level.
The potential applications of research in chemical biology are unlimited. A number of serious diseases that lack effective treatments are currently being studied. Many of them will be discussed on 24-25 August when the University of Gothenburg and Chalmers University of Technology host the Functional Genomics/Chemical Biology conference in Gothenburg, Sweden:
- Professor Carsten Schultz from the European Molecular Biology Laboratory (EMBL) in Heidelberg is developing new tools that will help us better understand cystic fibrosis. By visualising how cell signaling goes awry, Schultz hopes to come closer to finding a treatment for the incurable disease.
- Ronald Raines from the University of Wisconsin has designed a ‘Trojan horse’ - an enzyme that infiltrates and then attacks the viruses that cause HIV and the lung disease SARS.
- Guri Giaever from the University of Toronto uses yeast to investigate the action mechanism of medicines. Giaver is working together with pharmaceutical companies to explore and eliminate side effects of medicines.
- Henrik Pavia is a University of Gothenburg marine ecologist and an expert in how marine organisms produce and utilise chemical substances. At the conference, Pavia will share the latest knowledge on how these marine bioactive substances can be used to create medicines for humans.
The conference, held at the Chalmers Conference Centre, will also present new findings about environmental toxins and the research currently carried out to identify how molecules in the cell are affected by the toxins.
Source:
Per Sunnerhagen
University of Gothenburg